Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Keda Yang, Fan Zhang, Baihua Luo & Zhan Qu. (2022) CAFs-derived small extracellular vesicles circN4BP2L2 promotes proliferation and metastasis of colorectal cancer via miR-664b-3p/HMGB3 pathway. Cancer Biology & Therapy 23:1, pages 404-416.
Read now
Read now
Qingjun Meng, Yanguang Li, Zhen Sun & Xue Yang. (2022) CircRNA hsa_circ_0070659 predicts poor prognosis and promotes non-small cell lung cancer (NSCLC) progression via microRNA-377 (miR-377) / Ras-Associated Binding Protein 3C (RAB3C) pathway. Bioengineered 13:6, pages 14578-14594.
Read now
Read now
Pengfei Li, Huina Lv, Yongkai Wu, Ke Xu, Min Xu & Yegang Ma. (2021) E2F transcription factor 1 is involved in the phenotypic modulation of esophageal squamous cell carcinoma cells via microRNA-375. Bioengineered 12:2, pages 10047-10062.
Read now
Read now
Articles from other publishers (12)
Qiong Zou, Yuping Zhang, Daoqi Zhu, Xinrong Liu, Changfa Wang & Hong Xiang. (2023) CircMMP11 as a prognostic biomarker mediates miR-361-3p/HMGB1 axis to accelerate malignant progression of hepatocellular carcinoma. Open Medicine 18:1.
Crossref
Crossref
Xuezhong Wang, Zhiguang Liu, Yalong Du, Shuguang Hao & Bing Zhao. (2023) Hsa_circ_0043603 promotes the progression of esophageal squamous cell carcinoma by sponging miR-1178–3p and regulating AADAC expression. Heliyon 9:9, pages e19807.
Crossref
Crossref
Zhangya Pu, Dan G. Duda, Yuanyuan Zhu, Siya Pei, Xiaofang Wang, Yan Huang, Panpan Yi, Zebing Huang, Fang Peng, Xingwang Hu & Xuegong Fan. (2022) VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway. Journal of Translational Medicine 20:1.
Crossref
Crossref
Janusz Matuszyk. (2022) MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy. Molecular Medicine 28:1.
Crossref
Crossref
Jie Tang, Jiawei Chen, Yongqiang Wang & Shaobo Zhou. (2022)
The role of
MiRNA
‐433 in malignant tumors of digestive tract as tumor suppressor
. Cancer Reports 5:9.
Crossref
Crossref
Chenxi Ju, Jing He, Chang Wang, Jinxiu Sheng, Jinlin Jia, Dan Du, Hongle Li, Mingxia Zhou & Fucheng He. (2022) Current advances and future perspectives on the functional roles and clinical implications of circular RNAs in esophageal squamous cell carcinoma: more influential than expected. Biomarker Research 10:1.
Crossref
Crossref
Yunxia Fu, Chunyan Qiu, Yanjun Yang, Jianying Lu & Yun Qi. (2021) CircLPAR3 Acts as an Oncogene in Oral Squamous Cell Carcinoma Through Regulating the miR-643/HMGB2 Network. Biochemical Genetics 60:3, pages 882-898.
Crossref
Crossref
Zhijian Su, Chao Pan, Honghui Xie, Yanyang Ning, Shuangjiang Li & Haibo Xiao. (2022) Downregulation of circLPAR3 inhibits tumor progression and glycolysis by liberating miR‐144‐3p and upregulating LPCAT1 in oral squamous cell carcinoma. Laryngoscope Investigative Otolaryngology 7:2, pages 425-436.
Crossref
Crossref
Yao Cheng, Zhenchuan Ma, Shiyuan Liu, Xiaoping Yang & Shaomin Li. (2022) CircLPAR3 knockdown suppresses esophageal squamous cell carcinoma cell oncogenic phenotypes and Warburg effect through miR-873-5p/LDHA axis. Human & Experimental Toxicology 41, pages 096032712211436.
Crossref
Crossref
Li Li, Ye Yin, Fanglong Nan & Zeyu Ma. (2022) Circ_LPAR3 promotes the progression of oral squamous cell carcinoma (OSCC). Biochemical and Biophysical Research Communications 589, pages 215-222.
Crossref
Crossref
Xin Fang, Sachin Mulmi Shrestha, Li‐Hua Ren & Rui‐hua Shi. (2021) Biological and clinical implications of metastasis‐associated circular RNAs in oesophageal squamous cell carcinoma. FEBS Open Bio 11:11, pages 2870-2887.
Crossref
Crossref
Jiahui Wei, Yiran Lu, Ruiqing Wang, Xiangzhu Xu, Qing Liu, Song He, Huihao Pan, Xinmiao Liu, Bao Yuan, Yu Ding & Jiabao Zhang. (2021) MicroRNA-375: potential cancer suppressor and therapeutic drug. Bioscience Reports 41:9.
Crossref
Crossref